|
Volumn 64, Issue 2, 2009, Pages 16-20
|
Diabetic retinopathy: a growing concern in an aging population.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
GLUCOCORTICOID;
MONOCLONAL ANTIBODY;
RANIBIZUMAB;
TRIAMCINOLONE;
AGED;
AGING;
BLINDNESS;
DIABETIC RETINOPATHY;
DRUG COMBINATION;
GERIATRICS;
HUMAN;
INCIDENCE;
INTRALESIONAL DRUG ADMINISTRATION;
LASER COAGULATION;
MASS SCREENING;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK FACTOR;
TREATMENT OUTCOME;
UNITED STATES;
AGED;
AGED, 80 AND OVER;
AGING;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
BLINDNESS;
CALIFORNIA;
DIABETIC RETINOPATHY;
DRUG THERAPY, COMBINATION;
GERIATRICS;
GLUCOCORTICOIDS;
HUMANS;
INCIDENCE;
INJECTIONS, INTRALESIONAL;
LASER COAGULATION;
MASS SCREENING;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK FACTORS;
TREATMENT OUTCOME;
TRIAMCINOLONE;
|
EID: 63049133469
PISSN: None
EISSN: 19365764
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (54)
|
References (21)
|